One 'oversold' ASX 200 healthcare share to buy today

After some big share price falls, is this ASX 200 healthcare stock trading for a bargain?

| More on:
Smiling couple looking at a phone at a bargain opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) healthcare share Ramsay Health Care Ltd (ASX: RHC) is in the green today following two trading days of heavy selling.

In afternoon trade on Tuesday, the Ramsay share price is up 0.5% at $40.58 a share.

That will come as welcome news to shareholders after the ASX 200 healthcare share closed down a precipitous 6.8% on Friday following the release of its full-year results.

That decline, however, looks to reinforce Shaw and Partners' Jed Richards' buy recommendation for Ramsay Health Care (courtesy of The Bull).

Why Ramsay shares could be bargain-priced

"Ramsay is Australia's biggest private hospital operator. It also operates in the UK and Europe," Richards explains.

He noted that the ASX 200 healthcare share had tumbled from $56.47 on 6 March to trade for $44.42 a share on 29 August. And shares have since declined to the current $40.58.

According to Richards:

In our view, the shares have been oversold. The company had a market capitalisation of more than $10 billion on 29 August. The company is well managed, and we expect RHC to improve in fiscal year 2025.

What's been happening with the ASX 200 healthcare share?

As mentioned up top, Ramsay reported its FY 2024 financial results on Friday, 30 August.

And those results revealed a difficult year for the private hospital operator.

While total revenue increased 9.4% year on year to $16.77 billion, earnings before interest and tax (EBIT from continuing operations) went the other direction, falling 0.4% to $998 million.

And feeling the impacts of cost inflation, the ASX 200 healthcare share reported a 2.6% decline in profit after tax from continuing operations, which came in at $271 million.

Despite the dip in profits, management pleased passive income investors with a final dividend of 40 cents per share, fully franked. That's up 60% from the prior final dividend. And it brings the full-year passive income payout to 80 cents per share.

This sees Ramsay shares trading on a fully franked dividend yield of 2.0%. And if you're looking to bag that final dividend, you'd best hurry. Ramsay shares trade ex-dividend tomorrow, 4 September. Meaning you'll need to own shares at market close today to have rights to that payout.

Eligible investors can then expect to see that passive income hit their bank account on 26 September.

Looking to the year ahead, the ASX 200 healthcare share forecasts growth in its net profit after tax from continuing operations in FY 2025. Though margin recovery is expected to be slow, impacted by ongoing inflationary pressures and investments in business enablement programs.

The Ramsay share price is down 24% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Has the Pro Medicus share price risen too high too quickly?

Pro Medicus shares have rocketed 173% since this time last year.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Mergers & Acquisitions

Own Sigma shares? Here's the latest on the Chemist Warehouse merger

One year ago today, the two companies announced plans to merge. We could now be just a few months away…

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

'Huge opportunity' ahead for this ASX 200 healthcare stock

The ASX 200 healthcare stock is facing a large untapped market for its lead products.

Read more »